Atypical Ventures

Atypical Ventures is an early-stage venture capital firm based in New York, United States, investing in technical founders building across hardware, software, and biotech — what it calls "atoms, bits, and cells." Its thesis centers on frontier, non-consensus technologies such as space infrastructure and satellite data centers, synthetic biology and organoid-based drug discovery, nuclear isotopes for SMRs and radiopharma, battery and grid technology, AI agents, and advanced developer tooling. It backs pre-seed and seed-stage technical founders — often first-time or research-background engineers and scientists — pursuing ideas that are not yet obvious to the broader market but are technically plausible. The firm writes initial checks of $500K–$1M, makes a small number of high-conviction investments per fund rather than spraying capital widely, and can provide hands-on support with talent, go-to-market testing, and narrative/positioning beyond the check. Founders can pitch the firm directly by email via its website.